{
  "case_id": "case_0028",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 46.19,
    "sex": "Female",
    "genderIdentity": "Transgender Male",
    "ancestry": "European"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- right midbrain.\n  \nAdditional signs indicate lesion possibly also involving:\n- left C5 spinal cord.",
      "structured_data": {
        "gt_lesions_english": [
          "left C5 myelopathy",
          "right midbrain"
        ],
        "ft_lesions_parsed": [
          {
            "location": "midbrain",
            "side": "right",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "right midbrain"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [
          "left C5 myelopathy"
        ],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 1,
        "additional_lesion_count": 0,
        "proportion_correct": 0.5,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.5,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- TB.\n\nOther possible differentials:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, SLE and Neurosyphilis.\n- Also feasible but of low probability: Lyme, Vasculitis, Sjogren's, ADEM, Beh\u00e7et's and Lymphoma.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Right paramedian midbrain infarction (posterior circulation ischaemic stroke) (plausible for unilateral brainstem; but atypical for unilateral spinal cord involvement)\n- Right midbrain cavernous malformation with recent haemorrhage (plausible for unilateral brainstem; but atypical for unilateral spinal cord involvement)\n- Intrinsic midbrain glioma (plausible for unilateral brainstem; but atypical for unilateral spinal cord involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Right paramedian midbrain infarction (posterior circulation ischaemic stroke)",
          "Brainstem demyelinating plaque due to multiple sclerosis",
          "Right midbrain cavernous malformation with recent haemorrhage",
          "Intrinsic midbrain glioma",
          "Midbrain tuberculoma or other granulomatous lesion"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "MS",
          "CNS_Tuberculosis"
        ],
        "missing_lesion_dx_keys": [
          "Infection_Lyme",
          "Syphilis",
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "CNS_Vasculitis",
          "Autoimmune_Myelitis_Sjogren",
          "ADEM",
          "Autoimmune_Myelitis_SLE",
          "Behcet_Disease",
          "CNS_Lymphoma",
          "MOGAD"
        ],
        "missing_common_names": [
          "Neurosyphilis",
          "NMOSD (AQP4+)",
          "Neurosarcoid",
          "SLE",
          "MOGAD"
        ],
        "missing_low_prob_names": [
          "Lyme",
          "Vasculitis",
          "Sjogren's",
          "ADEM",
          "Beh\u00e7et's",
          "Lymphoma"
        ],
        "additional_diagnoses": [
          "Right paramedian midbrain infarction (posterior circulation ischaemic stroke)",
          "Right midbrain cavernous malformation with recent haemorrhage",
          "Intrinsic midbrain glioma"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 3,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 13,
        "lesion_ddx_matched_count": 2,
        "lesion_ddx_missed_common_count": 5,
        "lesion_ddx_missed_low_prob_count": 6,
        "lesion_ddx_coverage_percentage": 0.15384615384615385
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Cervical Spine and Brain and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: ANA, CRP, ENA, ANCA, ESR, CSF (cytology).\n- Could also consider testing: anti-dsDNA, anti-MOG, TB, ACE, HIV, anti-AQP4, syphilis, lyme, CSF (flow cytometry).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "Non-contrast CT brain",
          "CT angiogram of head and neck",
          "MRI brain with diffusion-weighted imaging and gadolinium contrast",
          "MR angiography of intracranial vessels",
          "ECG",
          "Continuous cardiac telemetry",
          "Transthoracic echocardiogram",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "Coagulation screen",
          "Blood glucose",
          "HbA1c",
          "Fasting lipid profile",
          "Erythrocyte sedimentation rate",
          "C-reactive protein",
          "Autoimmune screen (ANA, ENA, ANCA, antiphospholipid antibodies)",
          "Thrombophilia screen",
          "Vitamin B12 level",
          "Lumbar puncture with CSF analysis including cell count, protein, glucose, oligoclonal bands, cytology and cultures",
          "MRI of cervical and thoracic spine with gadolinium contrast",
          "Visual evoked potentials"
        ],
        "all_identified_ft_keys": [
          "Lipid_Profile",
          "CRP",
          "Autoimmune_Screen_General",
          "Antithrombin_III",
          "Coagulation_Screen",
          "ENA_Panel",
          "LFT",
          "Vitamin_B12",
          "ECG",
          "Glucose_HbA1c",
          "U_and_E",
          "CSF_Oligoclonal_Bands",
          "Protein_S_Activity",
          "Blood_Cultures",
          "Protein_C_Activity",
          "CSF_General",
          "FBC",
          "ANA",
          "Antiphospholipid_Screen",
          "Cerebral_Angiography",
          "MRI_Cervical_Spine",
          "Chest_XRay",
          "Factor_V_Leiden",
          "MRI_Thoracic_Spine",
          "ANCA",
          "MRA_Head_Neck",
          "CSF_Cytology",
          "VEP",
          "MRI_Brain",
          "ESR",
          "Cardiac_Telemetry",
          "CT_Head"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "CSF_Flow_Cytometry",
          "TB_Screen",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "CSF_Cytology",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "ANA",
          "CRP",
          "ENA_Panel",
          "CSF_Cytology",
          "ANCA",
          "ESR"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "CSF_Flow_Cytometry",
          "TB_Screen",
          "Serum_ACE",
          "HIV_Test",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "Lyme_Serology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 3,
        "primary_tests_found_count": 3,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 15,
        "ddx_tests_found_count": 6,
        "ddx_tests_coverage_percentage": 0.4
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Timing of current symptoms not specified, so no indication whether this is a new relapse or an old deficit.\n\nDMTs: Inappropriate omission. The plan failed to consider this possible treatment option.\n  \nAdditional factors not mentioned:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Airway, breathing and circulation stabilisation with supplemental oxygen if needed, IV access and continuous monitoring",
            "timing": "Start Now",
            "reasons": [
              "Brainstem lesions can unpredictably compromise consciousness and respiratory drive",
              "Optimising oxygenation and perfusion limits secondary brain injury",
              "Physiological stability is required before and during urgent imaging and interventions"
            ]
          },
          {
            "treatment": "Urgent admission to a hyperacute stroke unit or intensive care setting",
            "timing": "Start Now",
            "reasons": [
              "Suspected posterior-circulation stroke needs close neurological and cardiorespiratory observation",
              "Early specialist stroke care is associated with better functional outcomes",
              "Facilitates rapid coordination of imaging and reperfusion therapies"
            ]
          },
          {
            "treatment": "Assessment for and administration of intravenous thrombolysis (alteplase) if eligibility criteria are met",
            "timing": "Start Now",
            "reasons": [
              "Intravenous thrombolysis is highly time dependent for acute ischaemic stroke",
              "Posterior-circulation infarcts can benefit substantially from early recanalisation",
              "Imaging and contraindication screening for thrombolysis must begin immediately at presentation"
            ]
          },
          {
            "treatment": "Assessment for and performance of mechanical thrombectomy if a treatable large-vessel occlusion is identified",
            "timing": "Start Now",
            "reasons": [
              "Basilar or proximal posterior cerebral artery occlusions are amenable to thrombectomy",
              "Brainstem strokes carry high morbidity and mortality without recanalisation",
              "Endovascular therapy is most effective when arranged rapidly after vascular imaging"
            ]
          },
          {
            "treatment": "Aspirin 300 mg once daily followed by 75\u2013100 mg daily (or alternative antiplatelet regimen) for confirmed non-cardioembolic ischaemic stroke",
            "timing": "Delay",
            "reasons": [
              "Antiplatelet therapy should begin only after intracranial haemorrhage is excluded on imaging",
              "If intravenous thrombolysis is used, aspirin is delayed for 24 hours to reduce haemorrhagic transformation risk"
            ]
          },
          {
            "treatment": "High-intensity statin therapy (e.g., atorvastatin 80 mg daily)",
            "timing": "Delay",
            "reasons": [
              "Initiated after safe oral or enteral administration is established",
              "High-intensity statins reduce risk of recurrent ischaemic stroke and other vascular events"
            ]
          },
          {
            "treatment": "Early multidisciplinary neurorehabilitation including physiotherapy, occupational therapy and speech and language therapy with formal swallow assessment",
            "timing": "Delay",
            "reasons": [
              "Started once medically stable, typically within 24\u201348 hours, to maximise neurological recovery",
              "Addresses hemiparesis, spasticity, ataxia and dysarthria",
              "Swallow assessment minimises aspiration risk and guides nutrition and hydration plans"
            ]
          },
          {
            "treatment": "High-dose intravenous methylprednisolone followed by an oral taper if imaging demonstrates an inflammatory or demyelinating midbrain lesion",
            "timing": "Delay",
            "reasons": [
              "Corticosteroids are first-line therapy for acute demyelinating brainstem lesions such as multiple sclerosis relapses",
              "Should only be commenced after vascular and infectious causes have been excluded to avoid masking alternative diagnoses or worsening infection"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone followed by an oral taper if imaging demonstrates an inflammatory or demyelinating midbrain lesion",
            "timing": "Delay",
            "reasons": [
              "Corticosteroids are first-line therapy for acute demyelinating brainstem lesions such as multiple sclerosis relapses",
              "Should only be commenced after vascular and infectious causes have been excluded to avoid masking alternative diagnoses or worsening infection"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Timing of current symptoms not specified, so no indication whether this is a new relapse or an old deficit.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Timing of current symptoms not specified, so no indication whether this is a new relapse or an old deficit."
        },
        "dmt_evaluation": {
          "ft_plan": null,
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Inappropriate omission. The plan failed to consider this possible treatment option.\n  \nAdditional factors not mentioned:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 3,
          "reasons_acknowledged": 2,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.6666666666666666
        },
        "dmt": {
          "decision_category": "inappropriate_omission",
          "is_unsafe": 1,
          "reasons_total": 4,
          "reasons_acknowledged": 0,
          "reasons_missed": 4,
          "reasons_coverage_percentage": 0.0
        }
      }
    }
  }
}